Cover Image

Safety and Efficacy of Bivalirudin versus Unfractionated Heparin Monotherapy in Patients with CAD and DM Undergoing PCI: A Retrospective Observational Study

Introduction. Optimal anticoagulants for patients with diabetes mellitus (DM) undergoing percutaneous coronary intervention (PCI) are unclear. This retrospective observational study is aimed at evaluating efficacy and safety of bivalirudin versus unfractionated heparin (UFH) monotherapy in patients...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jing Li (Author), Sanbao Chen (Author), Sicong Ma (Author), Mingque Yang (Author), Zizhao Qi (Author), Kun Na (Author), Miaohan Qiu (Author), Yi Li (Author), Yaling Han (Author)
Format:	Book
Published:	Hindawi-Wiley, 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effects of low-molecular-weight heparin and unfractionated heparin on patients with exertional heat stroke with thrombocytopenia: A prospective study
by: Li Cheng, et al.
Published: (2019)

Unfractionated Heparin Improves the Intestinal Microcirculation in a Canine Septic Shock Model
by: Heng Zhang, et al.
Published: (2021)

Variants of PEAR1 Are Associated With Outcome in Patients With ACS and Stable CAD Undergoing PCI
by: Fabian Stimpfle, et al.
Published: (2018)

Different signaling pathways involved in the anti-inflammatory effects of unfractionated heparin on lipopolysaccharide-stimulated human endothelial cells
by: Xu Li, et al.
Published: (2020)

Bivalirudin for cardiac catheterization in a pediatric patient with religious objection to the use of porcine-derived heparin
by: A. Caskey, et al.
Published: (2021)

Effects of Bemiparin, Dalteparin, and Unfractionated Heparin on Platelet Interaction With Human Subendothelium Under Flow Conditions
by: Jose Antonio González-Correa, et al.
Published: (2008)

Renal unit practitioners' knowledge, attitudes and practice regarding the safety of unfractionated heparin for chronic haemodialysis
by: Debra Ockhuis, et al.
Published: (2015)

Prescriber perceptions of the safety and efficacy of unfractionated heparin versus low molecular weight heparin in the acute treatment phase: a qualitative study
by: Danielle Green, et al.
Published: (2024)

Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia
by: Romanová T, et al.
Published: (2024)

The toxicokinetic profile of Dex40-GTMAC3 - a novel polysaccharide candidate for reversal of unfractionated heparin.
by: Emilia eSokolowska, et al.
Published: (2016)

The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients
by: Pineo GF, et al.
Published: (2012)

Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review
by: Han Zhong, et al.
Published: (2020)

Bivalirudin versus heparin in adult and pediatric patients with extracorporeal membrane oxygenation therapy: A systematic review and meta-analysis
by: Liyao Liu, et al.
Published: (2022)

The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
by: Min Ma, et al.
Published: (2022)

A meta‐analysis and cost‐minimization analysis of bivalirudin versus heparin in high‐risk patients for percutaneous coronary intervention
by: Ke‐Xin Sun, et al.
Published: (2021)

Potency evaluation of unfractionated heparins commercialized in Brazil through anti-factor Xa and anti-factor IIa chromogenic tests and coagulation assay
by: Renata Jurema Medeiros, et al.
Published: (2023)

Adverse drug reactions attributed to fondaparinux and unfractionated heparin in cardiovascular care unit: An observational prospective pilot study in a tertiary care hospital
by: Sahithi Sharma, et al.
Published: (2018)

Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
by: Abdul Hafeez Ahmad Hamdi, et al.
Published: (2017)

Novel Applications of Anticoagulation with Bivalirudin in Cardiac Surgery
by: R Pradeep Kumar, et al.
Published: (2020)

Bivalirudin Attenuates Thrombin-Induced Endothelial Hyperpermeability via S1P/S1PR2 Category: Original Articles
by: Haowen Ye, et al.
Published: (2021)

Does Rivaroxaban Better than Vitamin K Antagonists in Atrial Fibrillation Patients Undergoing PCI?
by: Maamar Kara, et al.
Published: (2016)

Interventions in reducing anxiety among patients undergoing percutaneous coronary intervention (PCI): an integrated literature review
by: Effita Piscesiana, et al.
Published: (2021)

Impact of Bivalirudin on Ischemia/Reperfusion Injury in Patients with Reperfused STEMI Assessed by Cardiac Magnetic Resonance
by: Yizhi Zhang, et al.
Published: (2024)

Age–Bilirubin–International Normalized Ratio (INR)–Creatinine (ABIC) Score, a Potential Prognostic Model for Long-Term Mortality of CAD Patients After PCI
by: Wu TT, et al.
Published: (2023)

Association of Pre-PCI Blood Pressure and No-Reflow in Patients with Acute ST-Elevation Coronary Infarction
by: Xiaobo Li, et al.
Published: (2024)

Quantitation of bivalirudin, a novel anticoagulant peptide, in human plasma by LCâMS/MS: Method development, validation and application to pharmacokinetics
by: Xiao-Jiao Li, et al.
Published: (2013)

Role of Metformin Monotherapy Vs Metformin Plus Dapagliflozin in New Onset T2DM Among 40 Plus Obese Women in Glycaemic Control
by: Amarjeet Singh, et al.
Published: (2024)

Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI
by: Zhao X, et al.
Published: (2021)

Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention
by: Wang M, et al.
Published: (2015)

The Effect of High-intensity Interval Training (HIIT) with Short Intervals and Inactive Recovery on Cardiorespiratory Fitness and Health-related Quality of Life in Men with Hypertension and CAD after Percutaneous Coronary Intervention (PCI)
by: Khalilollah Moonikh Moonikh, et al.
Published: (2023)

Distribution of traditional Chinese medicine pattern types and prognostic risk factors in patients undergoing percutaneous coronary intervention (PCI): a systematic review and meta-analysis
by: L.I. Jieyun, et al.
Published: (2024)

Effect of low-molecular-weight heparin in women undergoing frozen-thawed embryo transfer cycles: a retrospective cohort study
by: Bo Sun, et al.
Published: (2023)

PERBANDINGAN LUARAN KLINIS SETELAH TINDAKAN CORONARY ARTERY BYPASS GRAFTING (CABG) DENGAN PERCUTANEOUS CORONARY INTERVENTION (PCI) PADA PASIEN CORONARY ARTERY DISEASE (CAD) DENGAN GANGGUAN FUNGSI GINJAL : SYSTEMATIC REVIEW
by: Dhiya Putri Aqilah Sandha,
Published: (2023)

Does Neutrophil Gelatinase-Asociated Lipocalin Have Prognostic Value in Patients with Stable Angina Undergoing Elective PCI? A 3-Year Follow-Up Study
by: Hanna Bachorzewska-Gajewska, et al.
Published: (2013)

Oxcarbazepine Monotherapy
by: J Gordon Millichap
Published: (2006)

Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
by: Bin Tu, et al.
Published: (2022)

POST-PCI CARE IN THE COVID-19 ERA - DELIVERY CHALLENGES AND HEALTH OUTCOMES:
by: Lina Du, et al.
Published: (2023)

Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
by: Janis Kay Shute
Published: (2023)

Heparin Mimetics: Their Therapeutic Potential
by: Shifaza Mohamed, et al.
Published: (2017)

Heparin: Past, Present, and Future
by: Eziafa I. Oduah, et al.
Published: (2016)